Wilms tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia

Leukemia and Lymphoma

Volumn 30, Issue 1-2, 1998, Pages 55-61

  Sugiyama, Haruo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Leukemia; Minimal residual disease; WT1

Indexed keywords

DNA MARKER; TUMOR MARKER;

ASSAY; BLAST CELL; CANCER GENETICS; CELL STRAIN K 562; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMOGENESIS; MINIMAL RESIDUAL DISEASE; NEPHROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031866863     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050929     Document Type: Review

References (35)

1. Campana, D. and Pui, C-H. (1995). Detection of minimal residual disease in acute leukemia: Methodologie advances and clinical significance. Blood, 85, 1416-1434.
2. Gray, J. W., Kuo, W. L., Liang, J., Pinkel, D., Van den Engh, G., Trask, B., Tkachuk, D., Waldman, F. and Westbrook, C. (1990). Analytical approaches to detection and characterization of disease-linked chromosome aberrations. Bone Marrow Transplant., 6, 14-19.
3. Yamada, M., Hudson, S., Tournay, O., Bittenbender, S., Shane, S. S., Lange, B., Tsujimoto, Y., Caton, A. J. and Rovera, G. (1989). Detection of minimal disease in haemopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc. Natl. Acad. Sci. U.S.A., 86, 5123-5127.
4. MacIntyre, E. A., d'Auriol, L., Duparc, N., Leveger, G., Galibert, F. and Sigaux, F. (1990). Use of oligonucleotide probes directed against T-cell antigen receptor gamma delta variable (diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J. Clin. Invest., 86, 2125-2135.
5. Shtivelman, E., Lifshitz, B., Gale, R. P. and Canaani, E. (1985). Fused transcript of abl and ber genes in chronic myelogenous leukemia. Nature, 315, 550-554.
6. Fainstein, E., Marcelle, C., Rosner, A., Canaani, E., Gale, R. P., Dreazen, O., Smith, S. D. and Croce, C. M. (1987). A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukemia. Nature, 330, 386-388.
7. Kawasaki, E. S., Clark, S. S., Coyne, M. Y., Smith, S. D., Champlin, R., Witte, O. N. and McCormick, F. P. (1988). Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. U.S.A., 85, 5698-5702.
8. Kakizuka, A., Miller, W. H. Jr., Umesono, K., Warrell, R. P. Jr., Frankel, S. R., Murty, V. V. V. S., Dmitovsky, E. and Evans, R. M. (1991). Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RAR-α with a novel putative transcription factor, PML. Cell, 66, 663-674.
9. de The, H., Lavau, C., Marcio, A., Chomienne, C., Degos, L. and Dejean, A. (1991). The PML-RAR-α fusion mRNA generated by the t(15:17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-684.
10. Giguere, V., Ong, E. S., Segui, P. and Evans, R. M. (1987). Identification of a receptor for the morphogen retinoic acid. Nature, 330, 624-629.
11. Miller, W. H. Jr., Kakizuka, A., Frankel, S. R., Warrell, R. P. Jr., DeBlasio, A., Levine, K., Evans, R. M. and Dmitovsky, E. (1992). Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA., 89, 2694-2698.
12. Downing, J. R., Head, D. R., Curcio-Brint, A. M., Hulshof, M. G., Motroni, T. A., Raimondi, S. C., Carroll, A. J., Drabkin, H. A., Willman, C., Theil, K. S., Civin, C. I. and Erickson, P. (1993). An AMLI/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood, 81, 2860-2865.
13. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T. Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T. and Kishimoto, T. (1994). WT1 as new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079.
14. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., Jones, C. and Housman, D. E. (1990). Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60, 509-520.
15. Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H. and Bruns, G. A. P. (1990). Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-778.
16. Coppes, M. J., Campbell, C. E. and Williams, B. R. G. (1993). The role of WT1 in Wilms tumorigenesis. FASEB J., 7. 886-895.
17. Rauscher, F. J. III (1993). The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7, 896-903.
18. Haber, D. A., Park, S., Maheswaran, S., Englert, C., Re, G. G., Hazen-Martin, D. J., Sens, D. A. and Garvin, A. J. (1993). WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science, 262, 2057-2059.
19. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P. and Rauscher, F. J. III (1992). Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science, 257, 674-678.
20. Gashler, A. L., Bonthron, D. T., Madden, S. L., Rauscher, F. J. III, Collins, T. and Sukhatme, V. P. (1992). Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl. Acad. Sci. U.S.A., 89, 10984-10988.
21. Harrington, M. A., Konicek, B., Song, A., Xia, X-L., Fredericks, W. J. and Rauscher, F. J. III (1993). Inhibition of colony-stimulating faclor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem., 268, 21271-21275.
22. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., Rauscher, F. J. III, Sens, D. A., Garvin, A. J., LeRoith, D. and Roberts, C. T. Jr. (1993). Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. U.S.A., 90, 5828-5832.
23. Hewitt, S. M., Hamada, S., McDonnel, T. J., Rauscher, F. J. III and Saunders, G. F. (1995). Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res., 55, 5386-5389.
24. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M. and Housman, D. E. (1991). Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad Sci. U.S.A., 88, 9618-9622.
25. Buckler, A. J., Pelletier, J., Haber, D. A., Glaser, T. and Housman, D. E. (1991). Isolation.characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol. Cell. Biol., 11, 1707-1712.
26. Park, S., Schalling, M., Bernard, A., Maheswaran, S., Shipley, G. C., Roberts, D., Fletcher, J., Shipman, R., Rheinwald, J., Demetri, G., Griffin, J., Minden, M., Housman, D. E. and Haber, D. A. (1993). The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet., 4, 415-420.
27. Miwa, H., Beran, M. and Saunders, G. F. (1992). Expression of the Wilms tumor gene (WT1) in human leukemias. Leukemia, 6, 405-409.
28. Miyagi, T., Ahuja, H., Kubota, T., Kubonishi, I., Koeffler, H. P. and Miyoshi, I. (1993). Expression of the Candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia, 7, 970-977.
29. Menssen, H. D., Renkl, H-J., Rodeck, U., Maurer, J., Notter, M., schwartz, S., Reinhardt, R. and Thiel, E. (1995). Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia, 9, 1060-1067.
30. Tamaki, H., Ogawa, H., Inoue, K., Soma, T., Yamagami, T., Miyake, S., Oka, Y., Oji, Y., Tatekawa, T., Tsuboi, A., Tagawa, S., Kitani, T., Miwa, H., Kita, K., Aozasa, K., Kishimoto, T. and Sugiyama, H. (1996). Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia. Blood, 88, 4396-4399.
31. Brieger, J., Weidmann, E., Fenchel, K., Mitrou, P. S., Hoelzer, D. and Bergmann, L. (1994). The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia, 8, 2138-2143.
32. Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, T., Oji, Y., Tamaki, H., Kyo, T., Dohy, H., Hiraoka, A., Masaoka, T., Kishimoto, T. and Sugiyama, H. (1996). Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood, 88, 2267-2278.
33. Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T. and Sugiyama, H. (1997). Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood, 89, 1405-1412.
34. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., Maekawa, T. and Kishimoto, T. (1996). Growth inhibition of human leukemic cells by WT1 (Wilmt tumor gene) anti-sense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis. Blood, 87, 2878-2884.
35. King-Underwood, L., Renshaw, J. and Pritchard-Jones, K. (1996). Mutations in the wilms' tumor gene WT1 in leukemias. Blood, 87, 2171-2179.